Astrazeneca Pharma India's Stock Sees Decline, 'Hold' Call Issued by MarketsMOJO

Astrazeneca Pharma India, a midcap pharmaceutical company, has been in the news recently due to its stock performance. On November 18, 2024, the company's stock saw a decline of -5.55%, closing at Rs 6400. This has led to a 'Hold' call on the stock by MarketsMOJO.

In terms of price performance, Astrazeneca Pharma India has underperformed the sector by -4.32% on the same day. The stock has also been on a downward trend for the past three days, with a fall of -13.64% during this period. The stock touched an intraday low of Rs 6384, a decline of -5.29%.

While the stock's performance may be a cause for concern for investors, it is worth noting that Astrazeneca Pharma India's moving averages are still higher than its 200 day moving average. However, it is currently lower than its 5 day, 20 day, 50 day, and 100 day moving averages.

In comparison to the Sensex, Astrazeneca Pharma India's performance has been -5.08% in the past day and -14.70% in the past month. This is in contrast to the Sensex's performance of -0.31% and -4.78% in the same time periods.

Overall, Astrazeneca Pharma India's recent stock performance has been a cause for concern for investors. However, it is important to note that this is just one aspect of the company and does not reflect its overall financial health or potential for growth. Investors are advised to do their own research and consult with a financial advisor before making any investment decisions.